KYOWA HAKKO BIO CO.,LTD. Sustainability Profile
Kyowa Hakko Bio Co., Ltd., a prominent player in the biotechnology industry, is headquartered in Japan. Established in 1949, the company has made significant strides in the development of amino acids, nucleic acids, and fermentation products, catering to diverse sectors such as pharmaceuticals,
DitchCarbon Score
How does KYOWA HAKKO BIO CO.,LTD.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
KYOWA HAKKO BIO CO.,LTD.'s score of 86 is higher than 91% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
KYOWA HAKKO BIO CO.,LTD.'s reported carbon emissions
In 2023, Kyowa Hakko Bio Co., Ltd. reported total carbon emissions of approximately 305,000 kg CO2e. This figure includes 33,000 kg CO2e from Scope 1 emissions, 96,000 kg CO2e from Scope 2, and 176,000 kg CO2e from Scope 3 emissions. This represents a reduction from 2022, when total emissions were about 363,000 kg CO2e, with Scope 1 at 40,000 kg CO2e, Scope 2 at 131,000 kg CO2e, and Scope 3 at 193,000 kg CO2e. Kyowa Hakko Bio has shown a commitment to reducing its carbon footprint, although specific reduction targets or initiatives have not been disclosed. The company is a current subsidiary of Kirin Holdings Company, Limited, which influences its sustainability strategies and reporting. Emissions data and climate initiatives may be cascaded from Kirin Holdings, which is involved in various climate initiatives, including SBTi and CDP. Overall, Kyowa Hakko Bio's emissions data reflects a proactive approach to climate commitments, aligning with industry standards for transparency and accountability in carbon management.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2001 | 2002 | 2005 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|---|
| Scope 1 | 708,202,000 | 000,000,000 | 000,000,000 | 00,000 | 00,000 | 00,000 | 00,000 | 00,000 |
| Scope 2 | 1,176,000 | 0,000,000 | - | 000,000 | 000,000 | 000,000 | 000,000 | 00,000 |
| Scope 3 | 650,000 | 000,000 | - | 000,000 | 000,000 | 000,000 | 000,000 | 000,000 |
How Carbon Intensive is KYOWA HAKKO BIO CO.,LTD.'s Industry?
How Carbon Intensive is KYOWA HAKKO BIO CO.,LTD.'s Location?
KYOWA HAKKO BIO CO.,LTD.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
KYOWA HAKKO BIO CO.,LTD. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
